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Abstract
Problem. Children with severe asthma are more likely to be non-adherent with their
prescribed medications, often related to barriers. A holistic assessment of these patients
has been suggested, but is not typically performed in most pediatric asthma clinics. The
purpose of this project was to evaluate the effects of severe pediatric asthma clinic
services designed to perform holistic assessments and provide comprehensive care.
Methods. An observational, descriptive design was used to evaluate the Severe Asthma
Clinic for Kids (SACK) created in 2013 using a retrospective database review. A
convenience sample of data collected on all children treated in the clinic from January
2014 through January 2020 was evaluated.
Results. A total of 144 SACK patients (N=144) revealed 121 (84%) had more than one
visit to the clinic. During their initial visit, 94 (65.28%) reported at least one barrier to
care; however, the number of barriers steadily decreased to zero for those experiencing
at least six clinic visits. Caregiver’s quality of life scores increased 31% per visit
(p=0.0009), asthma control test scores increased 89% per visit (p<0.0001), and
medication refills increased to 5.98 refills per visit (p<0.0001). While lung function
studies had essentially no change (p=0.1157), the number of emergency (ED) visits and
hospitalizations was essentially zero.
Implications for Practice. The SACK clinic for children provided a multidisciplinary
approach to the evaluation and management of children with asthma. A multidisciplinary
team approach allowed for removal of barriers to care and improved the control of
asthma and quality of life for children.

MULTIDISCIPLINARY TEAM ON PEDIATRIC SEVERE ASTHMA

3

Multidisciplinary Team Approach Effect On Pediatric Severe Asthma
Asthma is a significant chronic condition in the U.S. affecting more than 25
million Americans, of whom six million (nearly 25%) are less than 18-years of age
(National Heart, Lung, and Blood Institute [NHLBI], 2007). In fact, asthma is the most
common chronic lung disease of childhood, characterized by variable and recurring
airflow obstruction, airway inflammation, and bronchial hyperresponsiveness. The
interaction between airway obstruction, inflammation and bronchial responsiveness
determines the clinical manifestations (i.e., cough, wheeze, shortness of breath, and/or
chest tightness), as well as the severity of the asthma (NHLBI, 2007). African American
or Puerto Rican male children, and those living below the Federal Poverty Level (FPL)
are at highest risk for developing asthma (American Academy of Asthma, Allergy, and
Immunology [AAAAI], 2019). Additionally, asthma is a leading cause of school
absenteeism in the U.S., accounting for almost 14 million missed days of school per year
(U.S. Department of Health & Human Services [HHS], 2018). Further, asthma has a
significant economic impact on the U.S. with direct and indirect costs of almost $82
billion annually (Nurmagambetov, Kuwahara, & Garbe, 2018). Almost half of costs
related to asthma are associated with patients with severe asthma due to the high
healthcare resource utilization needed by these patients (Nunes, Pereira, & MoraisAlmedia, 2017).
In the U.S., pediatric severe asthma affects 300,000-600,000 (5-10%) of the six
million children with asthma (Chung et al., 2014). While this population represents a
small portion of childhood asthma, associated burdens such as increased risk for adverse
events from medication use, life-threatening exacerbations, and decreased quality of life
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are higher in severe asthmatic children than in those children with less severe disease
(Nunes et al., 2017). Severe asthma is defined by the European Respiratory Society
(ERS) and the American Thoracic Society (ATS) as asthma in persons older than sixyears of age “which requires treatment with high dose inhaled corticosteroids (ICS) plus
a second controlled (and/or systemic corticosteroids) to prevent it from becoming
uncontrolled or which remains uncontrolled despite this therapy” (cited in Chung et al.,
2014, p. 349). While the ERS/ATS severe asthma definition does not include children
under the age of six-years, asthma management for young children remains personalized,
using a step-wise approach (Global Initiative for Asthma [GINA], 2019). Younger
children can be considered to have severe disease when attempts at lowering maintenance
asthma therapy develop into loss of asthma control (Marko & Ross, 2019).
Recent asthma practice recommendations stressed the importance of referral for
the patient with severe asthma to an asthma specialist for evaluation and management of
the disease (Scottish Intercollegiate Guidelines Network (SIGN) and British Thoracic
Society (BTS), 2019; GINA, 2019; NHLBI, 2007). Referral should be made to help
confirm the diagnosis of asthma, evaluate for co-morbid conditions, assess for barriers to
care, and for expertise in new asthma controller therapies. In addition, providing
coordinated care, including education about asthma management, could contribute to
decreased rates of asthma exacerbations requiring hospital admission (Kelly et al., 2015).
Despite the presence of pediatric severe asthma outpatient centers and clinics
throughout the U.S., there is paucity in the literature regarding the effect such clinics
have on the evaluation and management of children with severe asthma. The purpose of
this program evaluation was to better understand how a consistent, multidisciplinary
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approach to management of severe asthma in the pediatric patient impacted control of the
disease in a Midwestern, urban pediatric medical center with the highest rates of asthma
in the U.S. (Harris, 2019). The aim of this project was to determine the effectiveness of
asthma control and quality of life in pediatric patients with severe asthma whose asthma
is managed by a multidisciplinary team. The outcome measures of interest were: 1)
demographic variables, 2) Asthma Control Test (ACT) scores, 3) spirometry
measurements (first second of forced expiratory volume [FEV1] and fractional exhaled
nitric oxide level [FENO]), 4) oral corticosteroid use, 5) emergency department (ED)
visits, 5) hospitalizations, 6) Pediatric Asthma Caregiver Quality of Life Questionnaire
(PACQLQ) scores, and other screening instruments (e.g. Beck’s Depression Youth
Inventory or PHQ9-Modified, Health and Treatment Beliefs, Barrier Review, Social
History). The question for study was: What is the effect on asthma control and quality of
life from a multidisciplinary team approach for the treatment of the child with severe
asthma?
Literature Review
A literature search in PubMed, CINAHL Plus, and Medline Plus for publications
pertaining to the effects of pediatric multidisciplinary severe/refractory outpatient asthma
clinics on children with severe asthma produced no studies. The search was expanded to
national organizations associated with asthma and asthma practice guidelines, including
the AAAAI, SIGN and BTS, ERS and ATS, GINA, and the NHLBI. The search was
refined using the key search terms: multidisciplinary, severe, asthma, and pediatric using
the Boolean operators AND and OR. This resulted in 33 publications published between
the years 1995 through 2019. Inclusion criteria were studies on children with severe
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asthma and multidisciplinary teams or approaches. Thirty of the publications were
eliminated, since they did not pertain to care of the child with severe asthma or a multidisciplinary approach. One publication was a one-page abstract, not a detailed
publication, but was selected for review. The remaining two publications retrieved were
related to the intended information sought; therefore, an ancestry approach was used from
publications. Ultimately, 19 publications, four practice guidelines, and a book were
selected for this literature review.
Severe asthma in children is a heterogeneous disease consisting of multiple
phenotypes with a range of clinical, molecular, and cellular inflammatory attributes
(Ramratnam, Bacharier, & Guilbert, 2017). For instance, Liu et al. (2016) summarized
eight essential factors correlating asthma severity among inner city children with severe
asthma: sensitization, allergic inflammation, pulmonary physiology, stress, obesity,
vitamin D, environmental tobacco smoke (ETS) exposure, and rhinitis severity, including
pulmonary physiology, rhinitis severity, ETS exposure and allergic inflammation.
Similarly, the Severe Asthma Research Program (SARP) identified four clusters of
shared clinical, physiological, and biological characteristics of children with asthma
based on lung function, atopy, comorbidities, number of symptoms and medication use
(Fitzpatrick et al., 2011). Children with severe asthma were found in all clusters
(Fitzpatrick et al., 2011). Having an understanding of childhood-asthma phenotypes may
allow for more personalized asthma care and an increased likelihood of better asthma
outcomes (Ramratnamet al., 2017).
The ERS/ATS recommended comorbidities be addressed, inhaler technique
reviewed, and the diagnosis of asthma be confirmed before asthma is determined to be
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severe. In addition, adherence to prescribed asthma therapy should be assessed (Chung et
al., 2014). Past studies of asthma medication compliance have found adherence rates in
children with asthma to be approximately 55% (HHS, 2018); however, adherence in
children with severe asthma ranged from 28-67% (Boutopoulou, Koumpagioti, Matziou,
Priftis, & Douros, 2018). Moreover, there is an increased risk for poor adherence in
ethnic minorities and in persons of lower socioeconomic status (McQuaid, 2018).
Because of the potential confounding complexities and effects of the social
determinants of health on severe asthma, especially with the pediatric population, several
academic centers in the U.S. with experts in asthma care have created specialty clinics or
centers dedicated to the care of the children with severe asthma. The Severe Pediatric
Asthma Consortium is a group of pediatric allergists and pulmonologists from the U.S.
who collaborate efforts to develop standards of care for the child with severe asthma (E.
Forno, personal communication, June 10, 2019). The primary objective of the
Consortium is to standardize care of children with severe asthma. The Consortium is
currently comprised of seven academic sites and a combined clinical, translational, and
research approach is used by the Consortium to help to improve asthma outcomes in this
high-risk population. However, there are no publications from the Consortium regarding
clinical care of the child with severe asthma.
Three publications specific to a multidisciplinary approach to caring for the child
with severe asthma were found and reviewed. Capucilli, Amos, and DaVeiga (2018)
published an abstract reviewing asthma outcomes of 42 subjects who were cared for in
the Pulmonary Problematic Asthma (PAPA) clinic in Philadelphia, Pennsylvania. This
abstract concluded improved asthma outcomes were more likely to occur when
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multidisciplinary care was used to help the following: (a) decrease barriers to clinic visits,
and (b) address compliance with prescribed asthma therapy. The second publication, a
retrospective chart review of 141 high-risk asthma patients being cared for by the Asthma
Action Team (AAT) within a primary care setting in Boston, Massachusetts was
performed by Holder-Niles, et al. (2017). The authors found the use of a coordinated
asthma care program was associated with decreased urgent and emergency department
visits, as well as hospital admissions. The final study was a prospective study of 89
subjects who were electively hospitalized to receive care from an inpatient multidisciplinary asthma team in Europe (Verkleij, Beelen, van Ewikj, & Geenen, 2017).
These authors concluded asthma control was improved in the vast majority of patients
who were recipients of care provided by a multidisciplinary inpatient team. While all
three publications found coordinated asthma care was an effective approach to asthma
management for the child with severe asthma, there were no major trends or patterns, nor
relationships among studies of clinical outcomes to relate the multidisciplinary team
approach with the management of asthma in this population.
The NHLBI Asthma Guidelines (2007) do not provide recommendations for a
multidisciplinary approach specific to management of the pediatric patient with severe
asthma. However, general guidelines are provided to help assess asthma control in
pediatric patients with asthma. Asthma is considered to be well controlled if symptoms
of asthma (i.e., cough, wheeze, and/or shortness of breath) occur <2 days/week, and/or
there is need for 0-1 course of oral corticosteroids/year (NHLBI, 2007). Asthma is
classified as not well controlled if symptoms occur >2 days/week, and/or there is a need
for oral corticosteroids >2 times for year (NHLBI, 2007). Asthma is classified as being
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very poorly controlled if symptoms occur throughout the day, and/or there is a need for
oral corticosteroids >3 times/year (NHLBI, 2007). Finally, the NHLBI (2007) stated in
children aged 5-11 years, the FEV1 >80% predicted or FEV1/Forced Vital Capacity
(FEV1/FVC) >80% was a reflection of well controlled asthma; FEV1 60-80% predicted
or FEV1/FVC 75-80% was not well controlled asthma; and FEV1<60% predicted or
FEV1/FVC <75% was very poorly controlled asthma. Hence, monitoring for the
occurrence of symptoms, corticosteroid use, and FEV1 are indicated as objective
measures of asthma control.
Alternatively, the ACT is a validated patient-based subjective instrument used to
measure asthma control in the clinical setting (Schatz et al., 2006). The ACT is a
reflection of perceived asthma control over the previous month (Schatz et al., 2006). A
score greater than 19 is a reflection of well controlled asthma; 16-19 reflects asthma is
not well controlled; and a score less than16 reflects poorly controlled asthma (Schatz et
al., 2006). While objective measures are helpful, subjective measures may also be of
value when evaluating asthma control.
Likewise, the PACQLQ is a validated health-related quality of life, selfadministered screening instrument and is also a subjective measurement of a perceived
quality of life, but for the caregiver (Juniper et al., 1996). The PACQLQ measures two
problems encountered by primary caregivers of children with asthma: activity limitation
and emotional distress (Juniper et al., 1996). The PACQLQ is a reflection of the
perceived quality of life experienced by the caregiver within the past seven days in
relation to their child’s asthma condition (Juniper et al., 1996). When completed at
regular intervals, the PACQLQ screens for a clinically significant change in quality of
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life over time (Juniper et al., 1996). Including an assessment of the caregiver offers an
opportunity for a holistic assessment in the overall control of a child’s asthma condition
and its impact on the family.
In summary, asthma is a common chronic condition, but those with severe asthma
are at increased risk for poor asthma control and quality of life. While there are practice
guidelines to support the monitoring and maintenance of asthma control, there is a gap in
the literature on the effects of an outpatient, multidisciplinary team approach when caring
for children with severe asthma. In addition, little is known about pediatric severe asthma
(i.e., the role of phenotyping, risk for co-morbid conditions, adverse events such as
hospitalizations, and quality of life). A better understanding on the impact of a
multidisciplinary team care approach in an outpatient severe asthma clinic for children is
needed.
Finally, in a large, Midwestern, urban pediatric medical center with a Severe
Asthma Clinic for Kids (SACK), a program evaluation on its effect with this population
was needed and had never been done. The framework selected for the evaluation of this
program was the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model due
to its problem-solving approach in clinical decision-making. This model uses a three-step
process: creating a practice question, gathering the evidence, and translation of the
evidence into practice (The Johns Hopkins Hospital/Johns Hopkins University School of
Nursing, 2017). The goal of the JHNEBP is to incorporate research and best practices
into patient care (The Johns Hopkins Hospital/Johns Hopkins University School of
Nursing, 2017). The JHNEBP model has guided this project practice question and the
selection of outcome measures (data). Analysis of the data is expected to provide
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recommendations for improving practice, i.e., asthma control in children with severe
asthma.
Method
Design
This study was performed via an observational, descriptive design utilizing a
retrospective database review over a six-year period. Current practice has been to
complete a SACK Patient Assessment before and during each severe pediatric asthma
clinic visit, using multiple screening instruments by various multidisciplinary team
members (Appendix A). Screening instruments included ACT, Beck’s Depression
Inventory, the Patient Health Questionnaire Modified for Adolescents (PHQ-9), a Health
Belief Survey, a Treatment Regimen Survey, a (potential) Barrier Review, a Social
History, and PACQLQ. The database was created in 2014 and contains the SACK Patient
Assessment, including screening data. Data has been used for individual patient
evaluation of asthma control, however, evaluation of the data as a whole has never been
done. The period for data analysis was January 14, 2014 through January 14, 2020.
Setting
An outpatient clinic specifically designed for children with severe asthma
(SACK) at an urban, Midwestern pediatric medical center serving a metropolitan
population of over three million residents. The area has the highest rates of asthma in the
state (Harris, 2019). There are three pediatric hospitals within the metropolitan area, each
offering pediatric asthma, allergy, and pulmonology services. There are 144 patients
currently enrolled in SACK with a maximum of 12 patients (a combination of new
evaluation and return SACK visits) evaluated each month. The multidisciplinary team
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caring for the child included two pediatric pulmonologists, two pediatric allergists, a
certified pediatric nurse practitioner (CPNP) who was also a Certified Asthma Educator
(AE-C), a clinical nurse coordinator, a social worker, two asthma coaches, and
respiratory therapists employed in the pediatric pulmonary function lab. The average
time for the initial evaluation by the multidisciplinary team members is two-hours with
follow-up visits lasting approximately one-hour.
Sample
A convenience sample of children aged 3-18 years who were referred to the
SACK for evaluation and management of severe persistent uncontrolled asthma.
Inclusion criteria were age 3-18 years and patients who had been evaluated in the SACK
between January 14, 2014 and January 14, 2020. Exclusion criteria were patients under
three-years or older than 18-years of age, or who had not been evaluated in the SACK
between January 14, 2014 and January 14, 2020.
Approval Processes
Administrative approval from the medical center’s SACK was obtained. In
addition, the medical center’s institutional review board (IRB) approval was obtained to
perform data review and analysis of previously collected data associated with severe
asthma. Additional approvals from the doctor of nursing practice (DNP) committee and
university IRB was obtained. The greatest risk in this study was confidential information
accidentally revealed. To minimize this risk, all data was retrospective and was deidentified. Benefits of this study include enhanced knowledge of outcomes for asthma
control using a multidisciplinary team approach.
Data Collection/Analysis
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Data collected included demographic information: age, gender, race/ethnicity, zip
code, and payor status. Additional data collected were ACT scores, FEV1 and fractional
exhaled nitric oxide (FENO), oral corticosteroid use, ED visits, hospitalizations,
PACQLQ scores, Beck’s Depression Youth Inventory or PHQ9-Modified results, health
and treatment beliefs, reported barriers, and social history. All data was de-identified a
coded as 14-1, 14-2, 14-3 and so on for 2014 data and 15-1, 15-2, 15-3 and so on for
2015 data, and likewise for subsequent years. All data was stored on a passwordprotected computer and removable drive.
Study group subjects’ characteristics were presented as mean +/- standard
deviation for quantitative variables, and number with percentage for qualitative variables.
Random coefficient regression models were performed to detect change of medication
refill rate, FEV1, PACQLQ, and ACT over time. Individual SACK clinic visits were
treated as a categorical covariate to assess the change between each two visits, and also
treated as a continuous variable to obtain overall trend during study period. Medication
refill rate was determined by using the calculation of refills obtained/twelve months X
100%. Data was analyzed by SAS® (SAS Institute Inc., Cary, NC, USA) 9.4 version. For
all analyses, values of p < 0.05 were considered statistically significant.
Procedures
Current practice is to complete a SACK Patient Assessment before and during
each clinic visit (Appendix A). The assessment was designed to facilitate comprehensive
decision-making of the differential diagnoses for cough and wheeze, and to assess for comorbid conditions (e.g., depression, obesity, etc.) and barriers to care (e.g., social
history, treatment regimens, etc.). Parental or guardian asthma literacy is also screened
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via Health and Treatment Beliefs questionnaires during the initial evaluation. Finally, the
objective measurements of FEV1 and FENO is obtained at every clinic visit. Subjective
asthma control is measured via the ACT and the PACQLQ is used to monitor caregiver
quality of life in relation to their child’s asthma. Interventions are individualized, based
on the objective and subjective findings of each patient during a SACK visit. Changes to
medications, additional ancillary testing, referral to subspecialties, social work
involvement, and enrollment in an asthma coach program are all potential interventions.
Results
A total of 144 children (N=144) were evaluated in SACK during the study period
and 121 (84%) of them had more than one SACK visit. Mean age of patients was 10.43
(SD= 3.91) years; three years (n=2, 1%), four years (n=3, 2%), five years (n=11, 7%), six
years (n=9, 6%), seven years (n=14, 10%), eight years (n= 13, 9%), nine years (n=16,
11%), 10 years (n=11, 8%), 11 years (n=11, 8%), 12 years (n=7, 5%), 13 years (n=12,
8%), 14 years (n=7, 5%), 15 years (n=8, 6%), 16 years (n=11, 8%), 17 years (n=6, 4%),
18 years (n=3, 2%). The majority of the children were male (n=79, 55%) but there were
65 (45%) females. There were non-Hispanic (n=138, 96%), African Americans (n=87,
60%), Caucasians (n=42, 29%), mixed (n=15, 11%). Payor status included 103 (72%)
insured by Medicaid, 41(28%) had private insurance. Finally, 62 (43%) reported living in
an urban area, 51 (35%) live in a suburban area, 23 (16%) live in a rural area, 8 (6%) live
in a small town. Most reported living in one household (n=123, 85%), 21 (15%) lived in
multiple households. Most children were receiving combination therapy (inhaled
corticosteroid and long acting beta agonist) (n=137, 95%), but 11 (8%) of the children
were on monotherapy. Thirty-one children (22%) entered SACK with asthma biologic
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therapy previously prescribed. During initial evaluation, 65% (n=94) of SACK patients
reported at least barrier to care, with 82 (57%) reporting an economic barrier, 78 (54%)
reporting a social barrier. The mean medication refill rate was 48% ±28, The mean

FeNO level=36 ppb ± 35, mean FEV1=89% of predicted ± 20%, mean ACT score=16
± 5, mean PACQLQ score=4 ±1. The range for lifetime ED visits was 0-43,

hospitalizations 0-28, PICU admissions 0-12, and need for mechanical ventilation 0-3
occasions (Appendix C).
The majority of families who reported one or more barrier to care had a
significant decrease in barriers with subsequent SACK visits (Appendix D). There was a
decrease (60%) in reported barriers from the initial SACK visit to the first follow-up
SACK visit; all visits had >50% decrease in reported barriers to care. The highest drop
(62%) was noted at the third SACK follow-up visit.
Increase in medication refill rate was found to be statistically significant, with an
average increasing of 5.98 per visit (p<0.0001) (Appendix E). The rate of refills rose
from visit one (initial visit) to visit two from 41.7 to 83.3; from visit two to visit three
from 83.3 to 91.7. There was a decrease in refill rate from visit three to visit four from
91.7 to 50.0; all subsequent visits demonstrated an increase in rate of refills (with visits
five and seven at a rate of 100%).
PACQLQ score over time significantly increased by an average of 0.31 per visit
(p=0.0009) (Appendix F). The change in ACT score over time had an average increase
of 0.89 per visit (p<0.0001) (Appendix G).
Trend of FEV1 over time was not found to be significant (Appendix H).
Although, the trend suggests a slight decrease in FEV1 over time.
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When compared to baseline number of OCS courses, ED visits, and
hospitalizations (events in the twelve months prior to initial evaluation in SACK), the
weighted moving average of OCS courses, ED visits, and hospitalizations twelve months
after a patient’s initial visit in SACK remained unchanged (around zero) (Appendices I, J,
and K).
Discussion
The Severe Asthma Clinic for Kids protocol includes screening for barriers to
care (economic and social) at each visit. Barriers reported by caregivers are addressed by
the SACK team (primarily by the social worker) during the visit, as well post-visit via
follow-up phone calls. Barriers related to both economic and social restraints were
largely resolved, leading to the number of barriers reported by families significantly
decreasing over time (without evidence of recurrence.). This decrease in barriers may
account for our additional findings. As barriers were removed, there appeared to be a
concurrent increase in caregiver quality of life in relation to their child’s asthma as
demonstrated by the statistically significant increase in PACQLQ score. While we
cannot be certain why there is a consistent increase in quality life (as seen on the
PACQLQ), we theorize that such change is likely a result of the detailed attention given
to families who are a part of SACK. Families in SACK are given the opportunity to have
social work involvement, as well as support from our asthma coaches—services not
readily available in routine asthma clinic. The multidisciplinary team approach provided
to children and their families during a SACK visit not only allows for thorough education
related to asthma, and, as previously mentioned, addressing potential healthcare barriers,
but is part of SACK standard of care. The unique attention provided to patients and their
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families could lead to better quality of life related to asthma. An increase in PACQLQ
has been shown to correlate with caregivers whose children obtained asthma control
(Stelmach, et al., 2012). This control may be evidenced by our finding that children
who’s asthma is managed in SACK experience an increase in ACT score over time. The
ACT has been validated as a clinical practice screening tool that is an accurate measure
of controlled and not-well controlled asthma (Jia, et al., 2013). While it is a selfadministered questionnaire, it is a tool that allows clinicians to assess how effectively
asthma has been controlled. The change from the majority of SACK patients reporting
poorly controlled asthma (score of <15) during their initial evaluation, to not-well
controlled asthma (score of 16-19) with subsequent visits, and, as time progressed, to
well controlled asthma (score of >20), could be a result of the multi-disciplinary care
provided at each SACK visit. In addition, this increase in asthma control correlates with
the demonstrated overall increase in medication refill rate. While consistently obtaining
medications as prescribed does not guarantee adherence with these medications, the
increase in reported asthma control may be a direct result of more consistent use of
maintenance asthma medication. This increase in medication refills could be related to
the SACK families having a new-found ability to obtain medications—another possible
result of our team addressing reported healthcare barriers.
We did not find that FEVI was preserved in the SACK patients. The decrease in
FEVI could be explained by selection bias, i.e., the likelihood of a return SACK visit is
reflective of disease severity. In addition, as the number of return visits increased, the
sample size decreased, leading to a decrease in power. Another potential reason for no
overall improvement in FEV1 could be due to the nature of asthma in the pediatric
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patient, as it has been established that children with a history of persistent asthma and
impairment of lung function are at risk for a reduced growth pattern of lung function
(McGeachie, et al., 2016).
We did not demonstrate a decrease in oral corticosteroid courses, nor asthmarelated ED visits or hospitalizations. This could be due to the relatively low numbers of
each of these variables at baseline, the need for a higher number of subjects, our study
was observational and descriptive using a clinic population (i.e., this was not a clinical
trial), and/or not enough follow-up visits to demonstrate such changes.
The relationship between barriers to healthcare, caregiver’s quality of life in
relation to their child’s asthma, medication refill history/adherence, and asthma control is
potentially complex, but seem to have direct influence on one another. Our multidisciplinary approach to caring for children with severe asthma has demonstrated the
importance of identifying, then addressing barriers to care. Although we cannot
definitively say that removing barriers to care leads to better asthma control, our findings
indicate that by doing so, such an approach leads to better outcomes for the pediatric
patient with severe asthma. Further study involving a higher number of subjects, perhaps
via a collaboration between severe asthma clinics that comprise The Severe Pediatric
Asthma Consortium, is needed to better understand how to continue to improve clinical
care, as well as decrease the morbidity and mortality associated with severe asthma in the
pediatric patient.
Conclusion
Our multidisciplinary approach to care of the child with severe asthma
demonstrated the importance of identifying and addressing barriers to care, as it appears
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that attention to social and economic barriers leads to better outcomes in this population.
Removing barriers likely correlates with an increase in caregiver quality of life as it
relates to their child’s asthma, increase in medication refills, and increase in asthma
control. Continued attention to health care barriers as reported by caregivers of children
with severe asthma has the potential to increase and sustain asthma control in this group
of high-risk patients.
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Appendix A
Severe Asthma Clinic for Kids (SACK) Patient Assessment
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Appendix B
Data Collection Instrument
Inclusion Criteria

Category

Detail
ERS/ATS definition of severe asthma
and/or GINA Guidelines

Demographics

Age
Sex
Race
Ethnicity
Zip code
Insurance

Medical History

Lifetime:
Courses of oral corticosteroids
Emergency department visits
Hospital admissions
Pediatric intensive care unit admissions
Mechanical ventilation

Interval History

Courses of oral corticosteroids
Emergency department visits
Hospital admissions
Pediatric intensive care unit admissions
Mechanical ventilation

Co-Morbidities

Allergic rhinitis
Food allergy
Allergic bronchopulmonary aspergillus
Eczema
Sinusitis
Gastroesophageal reflux
Immune dysfunction
Depression (PHQ-9 or Beck’s Depression
Inventory)
Obstructive sleep apnea
Obesity

Asthma Control

Asthma Control Test

Caregiver Quality of Life

Paediatric Asthma Caregiver Quality of
Life Questionnaire

MULTIDISCIPLINARY TEAM ON PEDIATRIC SEVERE ASTHMA
Diagnostics

27

Lung Function
(FEV1, FEV1/FVC)
FeNO
Imaging
Chest x-ray
Chest CT
Sinus CT
Bone density scan
Lab Studies
Blood eosinophils
IgE
Serum allergy testing
Percutaneous skin testing
Sweat chloride
Procedures
Bronchoscopy
Ciliary biopsy
Polysomnogram

Medications

Inhaled corticosteroid
Inhaled corticosteroid with long-acting
bronchodilator
Long-acting muscarinic
Leukotriene receptor antagonist
Theophylline
Maintenance oral corticosteroids
Anti-IgE therapy
Anti-IL-5 therapy
Anti-IL-4 therapy
Short-acting bronchodilator
Ipratropium bromide

Adherence

Medication refill history
Subjective report

Health literacy

Health belief survey
Treatment belief survey

Barriers to care

Subjective report
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Appendix C
Baseline Demographics
Race
White
African American
Mixed
Ethnicity
Hispanic/Latino
Gender
Male
Female
Age of Child (Years)
Insurance (%Medicaid)
Living Area
Urban Area
Suburban Area
Rural Area
Small Town
Household
One Household
Multiple Households
Baseline Medications (multiple choices)
ICS
ICS/LABA
Baseline Biologic Usage
Barriers Assessed
Economic
Social
Medication Refill Rate (%)
Baseline FeNO Level
Baseline FEV1
Baseline ACT Score
Baseline PACQLQ Score
Baseline Serum Eosinophils
Lifetime ED Visits
Lifetime Hospitalizations
Lifetime PICU
Lifetime ETT
Lifetime BiPAP
Baseline ED Visits (past 12 months)
Baseline Hospitalizations (past 12 months)
Baseline PICU (past 12 months)
Baseline OCS (past 12 months)

42 (29.37%)
87 (60.41%)
15 (10.49%)
6 (4.17%)
79 (54.86%)
65 (45.14%)
10.43 ± 3.91
103 (71.53%)

10 (7-14)

[3 – 18]

41.67 (25 – 66.7)
22 (12 – 45)
92.5 (78 – 104)
16 (3.35 – 5.38)
4.19 (3.35 – 5.38)
400 (100 – 680)
10 (5 – 20)
3 (1 – 8)
1 (0 – 2)
0 (0 – 0)
0 (0 – 0)
2 (1 – 3)
1 (0 – 2)
0 (0 – 0)
3 (1 – 5)

[0 – 116.67]
[5 – 196]
[38 – 127]
[3 – 26]
[1.5 – 7]
[0 – 1600]
[0 – 43]
[0 – 28]
[0 – 12]
[0 – 3]
[0 – 3]
[0 – 24]
[0 – 8]
[0 – 4]
[0 – 10]

62 (43.06%)
51 (35.41%)
23 (12.5%)
8 (5.56%)
123 (85.42%)
21 (14.58%)
11 (7.64%)
137 (95.14%
31 (21.53%)
94 (65.28%)
82 (65.28%)
78 (54.17%)
48.42 ± 27.74
35.69 ± 34.81
89.22 ± 20.49
15.99 ± 5.09
4.28 ± 1.31
433.43 ± 351.52
12.14 ± 9.43
5.17 ± 5.15
1.21 ± 1.83
0.22 ± 0.55
0.23 ± 0.65
2.4 ± 2.9
1.13 ± 1.47
0.26 ± 0.6
3.39 ± 2.65

A total of 144 subjects were included in Table 1. Quantitative data was presented as mean ± standard
deviation, median with interquartile range and minimum and maximum were also presented. Qualitative data
was presented as N (%). Data was analyzed by SAS® (SAS Institute Inc., Cary, NC, USA) 9.4 version.
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Appendix E

The plot above shows the change of medication refill rate estimated values over time. The estimated values (black dots) and 95%
confidence intervals (black bars) were obtained from the model (visit was treated as categorical covariate). Also, a regression line was
added in the plot. The slope and P-value were obtained from another random coefficient model (visit was treated as a continuous
covariate). The regression line indicates the estimated medication refill rate had an average increasing of 5.98 per visit (p<0.0001).
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Appendix F

The plot above shows the change of PACQLQ total score over time. The estimated values (black dots) and 95% confidence intervals
(black bars) were obtained from the model (visit was treated as categorical covariate). Also, a regression line was added in the plot. The
slope and P-value were obtained from another random coefficient model (visit was treated as a continuous covariate). The regression line
indicates the PACQLQ score had an average increasing of 0.31 per visit (p=0.0009).

.
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Appendix G

The plot above shows the change of ACT score over time. The estimated values (black dots( and 95% confidence intervals (black bars) were
obtained from the model (visit was treated as categorical covariate). Also, a regression line was added in the plot. The slop and P-value were
obtained from another random coefficient model (visit was treated as a continuous covariate). The regression line indicated AC score had an
average increasing of 0.89 per visit (p<0.0001).
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Appendix H

The plot above shows the change of FEV1 over time. The estimated values (black dots) and 95% confidence intervals (black bars) were
obtained from the model (visit was treated as categorical covariate). Also, a regression line was added in the plot. The slope and P-values
were obtained from another random coefficient model (visit was treated as a continuous covariate). There is not a significant change of
FEV1 over time (p=0.1157)
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The loess line displays moving average over time and the line is very flat around 0 visit over time.
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The loess line displays moving average over time and the line is very flat around 0 visit over time.
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The loess line displays moving average over time and the line is very flat around 0 visit over time.
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